Results

Total Results: over 10,000 records

Showing results for "author year description".

9141. Standardizing Medication Error Event Reporting in the U.S. Department of Defense (pdf file)
      www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol4/Nosek.pdf
      March 01, 2004 - One study estimates that 7,000 deaths per year are attributable to preventable medication errors, while … Author affiliations U.S. … Summary of information submitted to MEDMARX in the year 2002. The quest for quality. … Centralized reporting Results Actions taken Discussion Lessons learned Conclusions Acknowledgments Author … None) /PDFXOutputCondition () /PDFXRegistryName (http://www.color.org) /PDFXTrapped /Unknown /Description

9142. Long Term Care e-Prescribing Standards Pilot Study - Final Report (pdf file)
      digital.ahrq.gov/sites/default/files/docs/page/Long%20Term%20Care%20e-Prescribing%20Standards%20Pilot%20Study%20-%20Final%20Report_0.pdf
      August 01, 2007 - ........................................................................................... 1 1.0 Description … The team worked aggressively throughout the first half of the year to develop and implement the technology … General and psychotherapeutic medication use in 328 facilities: a year 2000 national survey. … If this time is multiplied by a potential one new order per day for one year the time saved is 365 minutes … the salary of a licensed practical nurse of $11/hour, the cost savings would be approximately $67/year

9143. Part 2: Trends in Priorities of the Heckler Report—Care for Cardiovascular Diseases | Agency for Healthcare Research and Quality
      ce.effectivehealthcare.ahrq.gov/research/findings/nhqrdr/chartbooks/blackhealth/part2-cvd.html
      June 01, 2018 - failure per 100,000 population, by race, 2001-2013, and by area income, Blacks, 2013 Left Chart: Year … Inpatient deaths per 1,000 adult hospital admissions with heart attack, by race/ethnicity, 2001-2013 Year … At current rates of improvement, Whites could achieve the benchmark in a year and Hispanics in less than … a year.

9144. Episiotomy (Overuse): Report (pdf file)
      www.cahps.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/perinatal/chipra-0083-fullreport.pdf
      March 01, 2016 - Measure Description Please provide a non-technical description of the measure that conveys what it … A text description of the measure. 2. … Population – infants (29 days to 1 year) (specify age range): No. q. … Population – pre-school age children (1 year through 5 years) (specify age range): No. r. … Measure Description 1.D. Measure Owner 1.E.

9145. Episiotomy (Overuse): Report (pdf file)
      www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/perinatal/chipra-0083-fullreport.pdf
      March 01, 2016 - Measure Description Please provide a non-technical description of the measure that conveys what it … A text description of the measure. 2. … Population – infants (29 days to 1 year) (specify age range): No. q. … Population – pre-school age children (1 year through 5 years) (specify age range): No. r. … Measure Description 1.D. Measure Owner 1.E.

9146. Episiotomy (Overuse): Report (pdf file)
      www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/perinatal/chipra-0083-fullreport.pdf
      March 01, 2016 - Measure Description Please provide a non-technical description of the measure that conveys what it … A text description of the measure. 2. … Population – infants (29 days to 1 year) (specify age range): No. q. … Population – pre-school age children (1 year through 5 years) (specify age range): No. r. … Measure Description 1.D. Measure Owner 1.E.

9147. Episiotomy (Overuse): Report (pdf file)
      www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/perinatal/chipra-0083-fullreport.pdf
      March 01, 2016 - Measure Description Please provide a non-technical description of the measure that conveys what it … A text description of the measure. 2. … Population – infants (29 days to 1 year) (specify age range): No. q. … Population – pre-school age children (1 year through 5 years) (specify age range): No. r. … Measure Description 1.D. Measure Owner 1.E.

9148. Episiotomy (Overuse): Report (pdf file)
      www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/perinatal/chipra-0083-fullreport.pdf
      March 01, 2016 - Measure Description Please provide a non-technical description of the measure that conveys what it … A text description of the measure. 2. … Population – infants (29 days to 1 year) (specify age range): No. q. … Population – pre-school age children (1 year through 5 years) (specify age range): No. r. … Measure Description 1.D. Measure Owner 1.E.

9149. Episiotomy (Overuse): Report (pdf file)
      www.monahrq.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/perinatal/chipra-0083-fullreport.pdf
      March 01, 2016 - Measure Description Please provide a non-technical description of the measure that conveys what it … A text description of the measure. 2. … Population – infants (29 days to 1 year) (specify age range): No. q. … Population – pre-school age children (1 year through 5 years) (specify age range): No. r. … Measure Description 1.D. Measure Owner 1.E.

9150. Episiotomy (Overuse) (pdf file)
      ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/0083episiotomy.pdf
      March 01, 2016 - Measure Description Please provide a non-technical description of the measure that conveys what it … A text description of the measure. 2. … Population – infants (29 days to 1 year) (specify age range): No. q. … Population – pre-school age children (1 year through 5 years) (specify age range): No. r. … Measure Description 1.D. Measure Owner 1.E.

9151. Episiotomy (Overuse): Report (pdf file)
      ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/perinatal/chipra-0083-fullreport.pdf
      March 01, 2016 - Measure Description Please provide a non-technical description of the measure that conveys what it … A text description of the measure. 2. … Population – infants (29 days to 1 year) (specify age range): No. q. … Population – pre-school age children (1 year through 5 years) (specify age range): No. r. … Measure Description 1.D. Measure Owner 1.E.

9152. Episiotomy (Overuse): Report (pdf file)
      www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/perinatal/chipra-0083-fullreport.pdf
      March 01, 2016 - Measure Description Please provide a non-technical description of the measure that conveys what it … A text description of the measure. 2. … Population – infants (29 days to 1 year) (specify age range): No. q. … Population – pre-school age children (1 year through 5 years) (specify age range): No. r. … Measure Description 1.D. Measure Owner 1.E.

9153. Episiotomy (Overuse) (pdf file)
      www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/0083episiotomy.pdf
      March 01, 2016 - Measure Description Please provide a non-technical description of the measure that conveys what it … A text description of the measure. 2. … Population – infants (29 days to 1 year) (specify age range): No. q. … Population – pre-school age children (1 year through 5 years) (specify age range): No. r. … Measure Description 1.D. Measure Owner 1.E.

9154. Agency for Healthcare Research and Quality
      www.ahrq.gov/research/findings/studies/index.html?page=34
      January 01, 2024 - and Ethnic Minorities, Family Health and History Kirby JB , Nogueira LM , Zhao J AHRQ Author … The authors estimated the association between past disruptions in coverage (occurring at least 1 year … claims data from the Wakely Consulting Group ACA database including enrollees with continuous, full-year … enrollment in on-exchange or off-exchange ACA-qualified health plans during the 2019 contract year. … , Women, Prevention, Diagnostic Safety and Quality Barry MJ , Wolff TA , Pbert L AHRQ Author

9155. CER 221 Disposition of Comments: Pharmacologic and Nonpharmacologic Therapies in Adult Patients With Exacerbation of COPD (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-221-copd-comments_0.pdf
      October 11, 2019 - The current qualitative description is sufficient according to our clinical experts and other peer … Risk trajectories of readmission and death in the first year after hospitalization for chronic obstructive … Descriptions were presented at the end of study description for each KQ, pages 13, 22, 42, 45. … Peer reviewer #4 Results Page 42/302: Current description of the Evidence Base is superficial and does … This comment applies to the description of evidence base for all key questions.

9156. CER 221 Disposition of Comments: Pharmacologic and Nonpharmacologic Therapies in Adult Patients With Exacerbation of COPD (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-221-copd-comments_0.pdf
      October 11, 2019 - The current qualitative description is sufficient according to our clinical experts and other peer … Risk trajectories of readmission and death in the first year after hospitalization for chronic obstructive … Descriptions were presented at the end of study description for each KQ, pages 13, 22, 42, 45. … Peer reviewer #4 Results Page 42/302: Current description of the Evidence Base is superficial and does … This comment applies to the description of evidence base for all key questions.

9157. Update on the Methods of the U.S. Preventive Services Task Force: Estimating Certainty and Magnitude of Net Benefit (pdf file)
      www.uspreventiveservicestaskforce.org/home/getfilebytoken/4y3P9DxovKMEjNmVd2mrPp
      December 01, 2007 - For increased clarity, the USPSTF has changed its description of overall evidence of net benefit for … Ann Intern Med. 2007;147:871-875. www.annals.org For author affiliations, see end of text. … Preventive Services Task Force Levels of Certainty Regarding Net Benefit Level of Certainty* Description … screening would be ex- pected to prevent about 217 strokes for every 100 000 people screened over a 5-year … Current author addresses are available at www.annals.org. References 1. U.S.

9158. Update on the Methods of the U.S. Preventive Services Task Force: Estimating Certainty and Magnitude of Net Benefit (pdf file)
      www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/benefit.pdf
      December 01, 2007 - For increased clarity, the USPSTF has changed its description of overall evidence of net benefit for … Ann Intern Med. 2007;147:871-875. www.annals.org For author affiliations, see end of text. … Preventive Services Task Force Levels of Certainty Regarding Net Benefit Level of Certainty* Description … screening would be ex- pected to prevent about 217 strokes for every 100 000 people screened over a 5-year … Current author addresses are available at www.annals.org. References 1. U.S.

9159. Disposition of Comments for Screening for Glaucoma: Comparative Effectiveness (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/glaucoma-screening_disposition-comments.pdf
      April 01, 2012 - identified those with glaucoma (test accuracy) or followed participants for an extended time (at least 1 year … In the methods we stated that "We assessed outcomes for Key Questions 1, 2, 4, and 5 at one year of … Better description of this criteria would help to clarlify how this criteria was applied. … In our inclusion criteria, we outlined a minimum of one year for the assessment of outcomes. … For this reason, it would be useful to have added, perhaps as an appendix, a fairly detailed description

9160. Disposition of Comments for Screening for Glaucoma: Comparative Effectiveness (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/glaucoma-screening_disposition-comments.pdf
      April 01, 2012 - identified those with glaucoma (test accuracy) or followed participants for an extended time (at least 1 year … In the methods we stated that "We assessed outcomes for Key Questions 1, 2, 4, and 5 at one year of … Better description of this criteria would help to clarlify how this criteria was applied. … In our inclusion criteria, we outlined a minimum of one year for the assessment of outcomes. … For this reason, it would be useful to have added, perhaps as an appendix, a fairly detailed description